Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Serotonin receptor subtype mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N-dimethyltryptamine.

D G Spencer, T Glaser, J Traber

Psychopharmacology January 1, 1987 DOI: 10.1007/bf00179927 (opens in new tab) via PubMed

Summary

AI-generated from the abstract

Male Wistar rats learned to distinguish the effects of 5-OMe-DMT from saline in a two-lever operant chamber. Drugs that generalized to the 5-OMe-DMT stimulus included LSD, 8-OH-DPAT, BAY R 1531, ipsapirone, and buspirone, with potencies best correlating with binding affinities for the 5-HT1A serotonin receptor. Several other drugs did not generalize or did so only partially. Among serotonin receptor antagonists, only metitepine and pindolol fully blocked the 5-OMe-DMT stimulus. The data indicate strong involvement of the 5-HT1A receptor subtype in the interoceptive discriminative stimuli induced by 5-OMe-DMT, with a possible role for 5-HT2 agonism.

Study at a glance

Characteristics Animal study with drug discrimination paradigm Peer reviewed
Population Male Wistar rats
Interventions 5-OMe-DMT LSD 8-OH-DPAT BAY R 1531 ipsapirone buspirone quipazine bufotenin TFMPP RU 24969 citalopram clomipramine BAY K 8644 1-PP methysergide metergoline metitepine ketanserin pizotifen ritanserin pindolol
Dose 1.25 mg/kg
Citations 69
Key finding The 5-HT1A receptor subtype is strongly involved in the interoceptive discriminative stimuli induced by 5-OMe-DMT, with a possible role for 5-HT2 agonism.

Abstract

Male Wistar rats were trained to discriminate the interoceptive effects of 5-methoxy-N,N-dimethyltryptamine (5-OMe-DMT; 1.25 mg/kg, IP) from saline in a two-lever operant chamber. Following discrimination learning, the following drugs (with ED50 dose in mg/kg IP) dose-dependently generalized: lysergic acid diethylamide (LSD, 0.04), 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT, 0.11), 6-methoxy-4-(dipropyl-amino)-1,3,4,5-tetrahydrobenz(c,d)indole hydrochloride (BAY R 1531, 0.15), 5-OMe-DMT itself (0.63), ipsapirone (TVX Q 7821, 2.7), and buspirone (3.8). The potencies of these drugs in generalization tests were best correlated with their binding affinities for the 5-HT1A serotonin receptor subtype (as measured by displacement of 3H-ipsapirone in the hippocampus). Drugs not, or only partially generalizing included quipazine, bufotenin, m-trifluoromethylphenylpiperazine (TFMPP), 5-methoxy-3(1,2,3,6-tetrahydropyridine-4-yl)-1H-indole succinate (RU 24969), citalopram, clomipramine, 1,4-dihydro-2,6-dimethyl-3-nitro-4(2-trifluoromethylphenyl)-pyridine-5- carboxylate (BAY K 8644), the buspirone metabolite 1-pyrimidinyl-piperazine (1-PP), methysergide, metergoline, and metitepine. Of the last three compounds with antagonistic activity at 5-HT receptors, as well as ketanserin, pizotifen, and ritanserin, only metitepine and pindolol could fully block the 5-OMe-DMT stimulus. Pizotifen blocked the generalization of quipazine fully, that of 5-OMe-DMT only partially, and that of ipsapirone not at all. These data indicate that the 5-HT1A receptor subtype is strongly involved in the transduction of the interoceptive discriminative stimuli induced by 5-OMe-DMT, with 5-HT2 agonism also playing a possible role.

Comments

No comments yet.

Log in to comment